article · PLoS ONE

“We have to amplify what we saw at EBOVAC” – Assessing participant perceptions, attitudes, and acceptability of an ancillary care policy in an Ebola vaccine trial in the Democratic Republic of the Congo: A mixed methods study

Gwen Lemey
Jean‐Pierre Van Geertruyden
Vivi Maketa
Maha Salloum
Pierre Van Damme
Trésor Zola Matuvanga
Ynke Larivière
Raffaella Ravinetto
Solange Milolo
Hypolite Muhindo Mavoko
Patrick Mitashi
Sibyl Anthierens

2025Open accessUniversité de Kinshasa (UNIKIN)

Abstract

Both quantitative and qualitative findings show high endorsement for the AC policy support, regardless of participants' personal use. This acceptability study highlights the importance of AC in clinical trials and comprehensive participant care in research.

Research topics

Viral Infections and Outbreaks Research
Vaccine Coverage and Hesitancy
Global Maternal and Child Health

Sustainable Development Goals

1No Poverty

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1371/journal.pone.0325435

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.